Fortis Healthcare has announced its audited financial results for the quarter and financial year ended March 31, 2026. The company reported strong performance, with consolidated annual revenue reaching ₹9,12,784 lacs and a net profit of ₹1,06,419 lacs. The Board of Directors has recommended a final dividend of ₹1/- per equity share for FY 2025-26. Additionally, the company appointed a new Cost Auditor and approved its Corporate Social Responsibility policy.
Financial Performance Overview
Fortis Healthcare demonstrated robust growth for the year ended March 31, 2026. The consolidated revenue from operations stood at ₹9,12,784 lacs, compared to ₹7,78,275 lacs in the previous fiscal year. Net profit for the period rose significantly to ₹1,06,419 lacs from ₹80,938 lacs, reflecting strong operational efficiency. The Board has recommended a final dividend of ₹1/- per equity share (10% of the face value of ₹10/-), subject to shareholder approval at the upcoming Annual General Meeting.
Operational Segments and EBITDA
The company maintains two primary reportable segments: Healthcare and Diagnostics. For the full year, the Healthcare segment generated ₹7,77,269 lacs in revenue, while Diagnostics contributed ₹1,52,656 lacs. The consolidated EBITDA, excluding exceptional items and other non-operating factors, improved to ₹2,13,564 lacs for the fiscal year 2025-26, up from ₹1,65,488 lacs in the prior year.
Strategic Appointments and Governance
In addition to financial results, the company announced the appointment of M/s Jitender, Navneet & Co. as the Cost Auditor for the financial year 2026-27. The Board also reviewed and approved the latest Corporate Social Responsibility (CSR) policy, underscoring the company’s commitment to community welfare and sustainable development. The Board meeting held on May 22, 2026, also served as a platform to confirm the successful completion of the open offers for Fortis and Malar Hospitals as of November 10, 2025.
Ongoing Corporate Developments
The company continues to advance its structural reorganization, with several schemes of amalgamation and business transfers now effective. Notably, the acquisition of TMI Healthcare Private Limited, which operates the 125-bedded People Tree Hospital, was finalized on January 9, 2026, for a transaction value of ₹43,386 lacs. These strategic moves are designed to consolidate operational and establishment entities, optimizing the company’s healthcare delivery framework across its various locations.
Source: BSE
